bpc-157 oral administration for gut issues Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review BPC-157: Benefits, Dosing & Side

Absolute contraindications include: Active malignancy of any kind (GH and IGF-1 are growth-promoting signals) Active diabetic retinopathy (IGF-1 may worsen retinal vascularity) Pregnancy or breastfeeding Known hypersensitivity to any component of the formulation Pituitary tumours or untreated hypothalamic disease Relative contraindications requiring careful evaluation include pre-existing insulin resistance, type 2 diabetes, uncontrolled cardiovascular disease, and sleep apnoea (GH elevation can worsen upper airway tone in susceptible individuals)

Current research does not show that BPC-157 directly causes weight loss

Furthermore, its packaging also does not contain any known irritants, such as natural rubber latex, DEHP, and PVC, among others

For context, the fat-mass reductions reported in Billon 2024 roughly 25-30% in diet-induced obese mice over 28 days without exercise are large for a preclinical metabolic agent and explain why the "exercise mimetic" label stuck

There isnt a better form of BPC-157 only a better match for the situation

Bain JR, Mackinnon SE, Hunter DA (1989) Functional evaluation of complete sciatic, peroneal, and posterior tibial nerve lesions in the rat